Camelot Portfolios, LLC Abb Vie Inc. Transaction History

Camelot Portfolios, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 21, 2021	SELL	$102.3 - $112.62 $308,536 - $339,661	-3,016 Closed	0 $0
Q4 2020 Jan 27, 2021	SELL	$80.49 - $108.67 $22,456 - $30,318	-279 Reduced 8.47%	3,016 $323,000
Q3 2020 Oct 19, 2020	SELL	$85.91 - $100.83 $28,865 - $33,878	-336 Reduced 9.25%	3,295 $289,000
Q2 2020 Jul 30, 2020	SELL	$73.37 - $98.18 $221,430 - $296,307	-3,018 Reduced 45.39%	3,631 $356,000
Q1 2020 Apr 28, 2020	BUY	$64.5 - $97.79 $54,954 - $83,317	852 Added 14.7%	6,649 $507,000

Q4 2019 Jan 16, 2020	BUY	$72.13 - $90.25 $68,667 - $85,918	952 Added 19.65%	5,797 $513,000
Q3 2019 Oct 15, 2019	BUY	$62.98 - $75.72 $29,978 - $36,042	476 Added 10.89%	4,845 $367,000
Q2 2019 Jul 19, 2019	SELL	$65.7 - $83.98 $20,169 - $25,781	-307 Reduced 6.57%	4,369 $318,000
Q1 2019 Apr 25, 2019	SELL	$77.14 - $90.79 $2,237 - $2,632	-29 Reduced 0.62%	4,676 $377,000
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $198,595 - $244,921	-2,551 Reduced 35.16%	4,705 $434,000
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $4,978 - $5,535	56 Added 0.78%	7,256 $686,000
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $119,797 - $160,419	1,302 Added 22.08%	7,200 $681,000
Q4 2017 Feb 06, 2018	BUY	$89.56 - $98.21 $53,736 - $58,925	600 Added 11.33%	5,898 $570,000
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $370,065 - $472,687	5,298	5,298 $471,000

3,654

1.24B

15.5M

11.6M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $294B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

Stay updated on Camelot Portfolios, LLC with notifications on news.